InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（18 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
18
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Urist Marshall, Vice-Président Exécutif et Co-Responsable de la Recherche et des Investissements. Officer active across 1 company, notably Royalty Pharma plc. Aggregated, 26 reports have been logged. Breakdown: 0 buy · 18 sells. Total volume traded: €11.6m. Activity tracked since 7 May 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Urist Marshall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报26 总计
8,252 股0Class A Ordinary SharesSEC:0001838139-26-000024:0
13,684 股@ US$53.06470.0020% mcap11.4% 占其流量Class A Ordinary SharesSEC:0001838139-26-000016:0
19,970 股0Class A Ordinary SharesSEC:0001838139-26-000012:0
20,000 股@ US$41.09055.9% 占其流量Class A Ordinary SharesSEC:0001838139-26-000010:0
20,000 股@ US$40.25555.9% 占其流量Class A Ordinary SharesSEC:0001838139-26-000008:0
20,000 股@ US$39.51735.9% 占其流量Class A Ordinary SharesSEC:0001838139-26-000006:0
20,000 股@ US$40.78176.0% 占其流量Class A Ordinary SharesSEC:0001838139-26-000004:0
20,000 股@ US$38.48255.4% 占其流量Class A Ordinary SharesSEC:0001838139-26-000002:0
20,000 股@ US$39.3198.2% 占其流量Class A Ordinary SharesSEC:0001838139-25-000014:0
20,000 股@ US$38.37918.7% 占其流量Class A Ordinary SharesSEC:0001838139-25-000012:0
20,000 股@ US$38.3219.5% 占其流量Class A Ordinary SharesSEC:0001838139-25-000010:0
23,334 股@ US$39.152812.7% 占其流量Class A Ordinary SharesSEC:0001838139-25-000008:0
23,333 股@ US$39.927712.9% 占其流量Class A Ordinary SharesSEC:0001838139-25-000006:0
4,626 股0Class A Ordinary SharesSEC:0001838139-25-000004:0
2,772 股0Class A Ordinary SharesSEC:0001802768-25-000101:0
36,484 股0Class A Ordinary SharesSEC:0001802768-25-000031:0
23,333 股@ US$37.296512.7% 占其流量Class A Ordinary SharesSEC:0001209191-23-012883:0
70,000 股0Class A Ordinary SharesSEC:0001209191-23-010715:0
3,600 股@ US$43.05142.4% 占其流量Class A Ordinary SharesSEC:0001209191-22-043282:0
23,333 股@ US$43.18750.0031% mcap17.6% 占其流量Class A Ordinary SharesSEC:0001209191-22-039294:0
23,333 股@ US$39.85070.0029% mcap16.4% 占其流量Class A Ordinary SharesSEC:0000899243-22-018222:0
70,000 股0Class A Ordinary SharesSEC:0000899243-22-017656:0
16,566 股@ US$45.13234.9% 占其流量Class A Ordinary SharesSEC:0000950103-21-008573:0
14,566 股@ US$41.52484.0% 占其流量Class A Ordinary SharesSEC:0000950103-21-008458:0
1,900 股@ US$41.08370.5% 占其流量Class A Ordinary SharesSEC:0000950103-21-007749:0
26 条申报中的 25 条
About Urist Marshall
Urist Marshall is Executive Vice President and Co-Head of Research and Investments. He has 25 filings in total, and in the 25 sampled filings the transactions are sales, for total sales of EUR 11584031 between 2021-05-11 and 2026-05-15, at Royalty Pharma plc.
